PET imaging of T cells derived from umbilical cord blood

Leukemia

Volumn 23, Issue 3, 2009, Pages 620-622

  Singh, H ^a   Najjar, A M ^a   Olivares, S ^a   Nishii, R ^a   Mukhopadhyay, U ^a   Alauddin, M ^a   Manuri, P R ^a   Huls, H ^a   Lee, D A ^a   Dotti, G ^b   Bollard, C ^b   Simmons, P J ^c   Shpall, E J ^a   Champlin, R E ^a   Gelovani, J G ^a   Cooper, L J N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIALURIDINE; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLUMINESCENCE; DNA MODIFICATION; FUSION GENE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMAGING; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 62549120345     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.256     Document Type: Article

References (9)

1. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R et al Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998; 58: 4333-4341.
2. Singh H, Serrano LM, Pfeiffer T, Olivares S, McNamara G, Smith DD et al. Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy. Cancer Res 2007; 67 2872-2880.
3. Serrano LM, Pfeiffer T, Olivares S, Numbenjapon T, Bennitt J, Kim D et al. Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood 2006; 107: 2643-2652.
4. Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, Cai S et al Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med 2008; 49: 1162-1170.
5. Lazovic J, Jensen MC, Ferkassian E, Aguilar B, Raubitschek A, Jacobs RE. Imaging immune response in vivo: Cytolytic action of genetically altered T cells directed to glioblastoma multiforme. Clin Cancer Res 2008; 14: 3832-3839.
6. Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A et al T-cell clones can be rendered specific for CD19: Toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood 2003; 101: 1637-1644.
7. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
8. 18F]FEAU. Nat Protoc 2007; 2: 416-423.
9. Jensen MC, Popplewell L, DiGiusto DL, Kalos M, Cooper LJN, Raubitschek A et al. A first-in-human clinical trial of adoptive therapy using CD19-specific chimeric antigen receptor redirected T cells for recurrent/ refractory follicular lymphoma. Mol Ther 2007; 15: S142.